Marking and Quantifying IL-17A-producing Cells in Vivo

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Jul 7

PMID 22768117

Citations 53

Authors

April E Price

R Lee Reinhardt

Hong-Erh Liang

Richard M Locksley

Affiliations

Soon will be listed here.

Abstract

Interleukin (IL)-17A plays an important role in host defense against a variety of pathogens and may also contribute to the pathogenesis of autoimmune diseases. However, precise identification and quantification of the cells that produce this cytokine in vivo have not been performed. We generated novel IL-17A reporter mice to investigate expression of IL-17A during Klebsiella pneumoniae infection and during experimental autoimmune encephalomyelitis, conditions previously demonstrated to potently induce IL-17A production. In both settings, the majority of IL-17A was produced by non-CD4(+) T cells, particularly γδ T cells, but also invariant NKT cells and other CD4(-)CD3ε(+) cells. As measured in dual-reporter mice, IFN-γ-producing Th1 cells greatly outnumbered IL-17A-producing Th17 cells throughout both challenges. Production of IL-17A by cells from unchallenged mice or by non-T cells under any condition was not evident. Administration of IL-1β and/or IL-23 elicited rapid production of IL-17A by γδ T cells, invariant NKT cells and other CD4(-)CD3ε(+) cells in vivo, demonstrating that these cells are poised for rapid cytokine production and likely comprise the major sources of this cytokine during acute immunologic challenges.

Citing Articles

Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity.

Copland A, Mackie G, Scarfe L, Jinks E, Lecky D, Gudgeon N EMBO Mol Med. 2024; 16(12):3057-3088.

PMID: 39558103 PMC: 11628626. DOI: 10.1038/s44321-024-00159-2.

Disruption of post-thymic tolerance in skin-reactive TCR transgenic mice through the interaction of lymphopenia and intestinal microbiota.

Hayabuchi H, Tokifuji Y, Takahashi H, Amagai M, Yoshimura A, Chikuma S Int Immunol. 2024; 36(8):413-424.

PMID: 38576231 PMC: 11245856. DOI: 10.1093/intimm/dxae018.

Triphasic production of IFN by innate and adaptive lymphocytes following influenza A virus infection.

Finney G, Hargrave K, Pingen M, Purnell T, Todd D, MacDonald F Discov Immunol. 2023; 2(1):kyad014.

PMID: 37842651 PMC: 10568397. DOI: 10.1093/discim/kyad014.

Deep tissue infection by an invasive human fungal pathogen requires lipid-based suppression of the IL-17 response.

Basso P, Dang E, Urisman A, Cowen L, Madhani H, Noble S Cell Host Microbe. 2022; 30(11):1589-1601.e5.

PMID: 36323314 PMC: 9744107. DOI: 10.1016/j.chom.2022.10.004.

Gearing up for battle: Harnessing adaptive T cell immunity against gram-negative pneumonia.

Gao C, Morales-Nebreda L, Pickens C Front Cell Infect Microbiol. 2022; 12:934671.

PMID: 36061870 PMC: 9433749. DOI: 10.3389/fcimb.2022.934671.

References

Martin B, Hirota K, Cua D, Stockinger B, Veldhoen M . Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity. 2009; 31(2):321-30. DOI: 10.1016/j.immuni.2009.06.020. View

Ye P, Garvey P, Zhang P, Nelson S, Bagby G, Summer W . Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol. 2001; 25(3):335-40. DOI: 10.1165/ajrcmb.25.3.4424. View

Happel K, Dubin P, Zheng M, Ghilardi N, Lockhart C, Quinton L . Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med. 2005; 202(6):761-9. PMC: 2212952. DOI: 10.1084/jem.20050193. View

Cua D, Tato C . Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010; 10(7):479-89. DOI: 10.1038/nri2800. View

Moore T, Perry M, Getsoian A, Newstead M, Standiford T . Divergent role of gamma interferon in a murine model of pulmonary versus systemic Klebsiella pneumoniae infection. Infect Immun. 2002; 70(11):6310-8. PMC: 130357. DOI: 10.1128/IAI.70.11.6310-6318.2002. View

Mangan P, Harrington L, OQuinn D, Helms W, Bullard D, Elson C . Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006; 441(7090):231-4. DOI: 10.1038/nature04754. View

Chang S, Dong C . IL-17F: regulation, signaling and function in inflammation. Cytokine. 2009; 46(1):7-11. PMC: 2663007. DOI: 10.1016/j.cyto.2008.12.024. View

Willenborg D, Fordham S, Bernard C, Cowden W, Ramshaw I . IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol. 1996; 157(8):3223-7. View

Becher B, Durell B, Noelle R . Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest. 2002; 110(4):493-7. PMC: 150420. DOI: 10.1172/JCI15751. View

10.

Shibata K, Yamada H, Hara H, Kishihara K, Yoshikai Y . Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol. 2007; 178(7):4466-72. DOI: 10.4049/jimmunol.178.7.4466. View

11.

Ye P, Rodriguez F, Kanaly S, Stocking K, Schurr J, Schwarzenberger P . Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med. 2001; 194(4):519-27. PMC: 2193502. DOI: 10.1084/jem.194.4.519. View

12.

Buonocore S, Ahern P, Uhlig H, Ivanov I, Littman D, Maloy K . Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010; 464(7293):1371-5. PMC: 3796764. DOI: 10.1038/nature08949. View

13.

Lockhart E, Green A, Flynn J . IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol. 2006; 177(7):4662-9. DOI: 10.4049/jimmunol.177.7.4662. View

14.

Hirota K, Duarte J, Veldhoen M, Hornsby E, Li Y, Cua D . Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol. 2011; 12(3):255-63. PMC: 3040235. DOI: 10.1038/ni.1993. View

15.

Cai Y, Shen X, Ding C, Qi C, Li K, Li X . Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity. 2011; 35(4):596-610. PMC: 3205267. DOI: 10.1016/j.immuni.2011.08.001. View

16.

Jager A, Dardalhon V, Sobel R, Bettelli E, Kuchroo V . Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol. 2009; 183(11):7169-77. PMC: 2921715. DOI: 10.4049/jimmunol.0901906. View

17.

Kurschus F, Croxford A, Heinen A, Wortge S, Ielo D, Waisman A . Genetic proof for the transient nature of the Th17 phenotype. Eur J Immunol. 2010; 40(12):3336-46. DOI: 10.1002/eji.201040755. View

18.

Park H, Li Z, Yang X, Chang S, Nurieva R, Wang Y . A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005; 6(11):1133-41. PMC: 1618871. DOI: 10.1038/ni1261. View

19.

Aujla S, Chan Y, Zheng M, Fei M, Askew D, Pociask D . IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med. 2008; 14(3):275-81. PMC: 2901867. DOI: 10.1038/nm1710. View

20.

Sumaria N, Roediger B, Ng L, Qin J, Pinto R, Cavanagh L . Cutaneous immunosurveillance by self-renewing dermal gammadelta T cells. J Exp Med. 2011; 208(3):505-18. PMC: 3058585. DOI: 10.1084/jem.20101824. View